[go: up one dir, main page]

Kandemir et al., 2021 - Google Patents

In Vitro Evaluation of Synergy in Carbapenem-resistant Klebsiella pneumoniae Strains with Antibiotic Combinations of Meropenem, Fosfomycin, Colistin, and …

Kandemir et al., 2021

View PDF
Document ID
16759384161779749990
Author
Kandemir
Öksüz Z
Delialioğlu N
Aslan D
Serin M
Publication year
Publication venue
Mediterranean Journal of Infection Microbes and Antimicrobials

External Links

Snippet

Results: Of 52 strains, 11 had only carbapenem (MEM) resistance. Twenty-three of strains were also resistant to FOS, 27 to CS, and eight to TGC. When antibiotic combinations were compared, MEM+ FOS, MEM+ CS, and CS+ TGC showed the best synergy in our strains. By …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Similar Documents

Publication Publication Date Title
Kar et al. Detection of colistin resistance in carbapenem resistant Enterobacteriaceae by reference broth microdilution and comparative evaluation of three other methods
Avery et al. Prevalence of in vitro synergistic antibiotic interaction between fosfomycin and nonsusceptible antimicrobials in carbapenem-resistant Pseudomonas aeruginosa
Zhu et al. In vitro evaluation of antimicrobial combinations against imipenem-resistant Acinetobacter baumannii of different MICs
Tang et al. Molecular characteristics and in vitro effects of antimicrobial combinations on planktonic and biofilm forms of Elizabethkingia anophelis
Fleischhack et al. Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients
Elbadawi et al. Antimicrobial resistance surveillance among gram negative bacterial isolates from patients in khartoum state hospitals
Baron et al. Risk factors for acquisition of colistin-resistant Klebsiella pneumoniae and expansion of a colistin-resistant ST307 epidemic clone in hospitals in Marseille, France, 2014 to 2017
Bulens et al. Carbapenem-resistant Acinetobacter baumannii complex in the United States—An epidemiological and molecular description of isolates collected through the Emerging Infections Program, 2019
Kunz Coyne et al. Steno‐sphere: Navigating the enigmatic world of emerging multidrug‐resistant Stenotrophomonas maltophilia
Xiong et al. Mechanisms of ceftazidime/avibactam resistance in drug-naïve bacteraemic Enterobacterales strains without metallo-beta-lactamase production: associated with ceftazidime impedance
Antony et al. Comparative evaluation of colistin-Susceptibility testing in Carbapenem-Resistant Klebsiella pneumoniae using VITEK, colistin broth disc elution, and colistin broth microdilution
Moghnieh et al. Prescription patterns for tigecycline in severely ill patients for non-FDA approved indications in a developing country: a compromised outcome
Usman et al. Synergistic effects of gentamicin, cefepime, and ciprofloxacin on biofilm of Pseudomonas aeruginosa
Awuor et al. Monitoring the battleground: antimicrobial resistance, antibiofilm patterns, and virulence factors of wound bacterial isolates from patients in hospital system
Kandemir et al. In Vitro Evaluation of Synergy in Carbapenem-resistant Klebsiella pneumoniae Strains with Antibiotic Combinations of Meropenem, Fosfomycin, Colistin, and Tigecycline
Tozluyur Fosfomycin in the treatment of New Delhi Metallo-β-Lactamase-5 (blaNDM-5)-producing Escherichia coli infection
Silvestri Enteral vancomycin to control severe methicillin-resistant Staphylococcus aureus infections in the intensive care unit
Sah et al. Colistin and Tigecycline susceptibility among carbapenemase producing Enterobacteriaceae at a tertiary care hospital of South India
Mandell et al. A prospective randomized trial of ceftazidime versus cefazolin/tobramycin in the treatment of hospitalized patients with pneumonia
Ahmed et al. Determination of multidrug resistance and extended drug resistance pattern of Pseudomonas aeruginosa in clinical isolates of tertiary care hospital Lahore
Radeva et al. Antimicrobial resistance of Serratia marcescens causing blood stream infections in a large University Hospital in Bulgaria, an 8-year analysis (2016–2023)
Kumaraswamy et al. Colistin exerts potent activity against mcr+ Enterobacteriaceae via synergistic interactions with the host defense
Kandemir et al. Mediterr J Infect Microb Antimicrob 2021; 10: 51 Erişim: http://dx. doi. org/10.4274/mjima. galenos. 2020.2021. 51
Imeneo et al. Ceftolozane/tazobactam use and emergence of resistance: a 4-year analysis of antimicrobial susceptibility in Pseudomonas aeruginosa isolates in a tertiary hospital
Manohar et al. Detection of NDM-1, VIM-1 and AIM-type metallo-beta-lactamase genes in Gram-negative bacteria isolated from clinical samples in Tamil Nadu